The Manila Times

Sangamo Therapeutics Advances Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease

Data support potential of isaralgagene civaparvovec as a one-time, well tolerated and durable Fabry disease gene therapy to provide meaningful, multi-organ clinical benefits that could fundamentally s ...

Abeona Therapeutics Inc.: Abeona Therapeutics Provides Business Update Highlighting Building Momentum in ZEVASKYN Commercial Launch

Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced an update on the building momentum in the Company's launch of FDA-approved ZEVASKYN (prademagene ...

Sangamo Therapeutics, Inc.: Sangamo Therapeutics Advances Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease

Data support potential of isaralgagene civaparvovec as a one-time, well tolerated and durable Fabry disease gene therapy to provide meaningful, multi-organ clinical benefits that could fundamentally ...
The American Journal of Managed Care

Vitiligo Treatment and JAK Inhibitors: AAD President Susan Taylor, MD

Extent of disease: Patients with 10% or less vitiligo and particularly facial or limited lesions tend to benefit most from ...

These Are the Skin Cancer Prevention Tips Dermatologists Want Every Active Woman to Know

Outdoor training can mean major UV exposure. Dermatologists share practical SPF, timing, and reapplication tips for sweaty, sunny workouts.

How To Shield Yourself From Skin Cancer If You Exercise Outside, According to Dermatologists

Exercising in the open air requires a little extra effort when it comes to protection. It’s worth it, though. You can level up your SPF game and still enjoy a sweat session outside.
The American Journal of Managed Care

Patients With cSCC Generally Tolerate Immunotherapies but Should Know About Common Adverse Events: Todd Schlesinger, MD

Clinicians must consider patient comorbidities and therapy safety when selecting immunotherapy for cSCC, says Todd ...